Sandeep Laumas
Director · Unicycive Therapeutics, Inc.
IndividualSelling only
- 2025
- Jul 28, 2026
- 5
Other insiders active in the same sector
No other insider has filed at Sandeep Laumas's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Paul A. Mahon - $98.96M in UTHR purchases and sales in the last 12 months
- Herriot Tabuteau - $97.80M in AXSM purchases and sales in the last 12 months
- TCO GROUP HOLDINGS, L.P. - $92.50M in INNV purchases and sales in the last 12 months
- IGNITE AGGREGATOR LP - $92.50M in INNV purchases and sales in the last 12 months
- SUVRETTA CAPITAL MANAGEMENT, LLC - $90.98M in MANE purchases and sales in the last 12 months
- Steven Leonard Chapman - $89.87M in NTRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sandeep Laumas?
Sandeep Laumas is a corporate insider, tracked as Director of Unicycive Therapeutics, Inc. (UNCY). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sandeep Laumas submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Sandeep Laumas been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($702K) across all tracked filings.
